Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE says Afinitor and Imbruvica “may be removed” from Cancer Drugs Fund

August 18, 2016
Research and Development, Sales and Marketing Afinitor, Cancer Drugs Fund, Janssen, NICE, Novartis, imbruvica

NICE has published draft guidance advising the removal of Novartis’s Afinitor (everolimus) and Janssen’s Imbruvica (ibrutinib) from the Cancer Drugs …

News
chemo-web

Untested cancer drug suspected cause of three deaths at German alternative medicine centre

August 17, 2016
Research and Development 3-Bromopyruvate, Cancer, Germany, alternative medicine, patient deaths

The deaths of three patients at an alternative medicine clinic in Germany have prompted suspicion of a clinically untested cancer …

News
shutterstock_141299494

GSK, Roche and Novo back $86 million immuno-oncology startup

August 17, 2016
Research and Development CD47, Cancer, GSK, Novo, Roche, Tioma, oncology

Brisbane-based venture-stage biopharmaceutical company Tioma Therapeutics has announced it has raised $86 million in Series A venture financing for its …

News
praluent_75mg_pen_box_hr

Amgen, Sanofi cholesterol medicines “not cost-effective”, need to drop price by two-thirds

August 17, 2016
Research and Development, Sales and Marketing Amgen, QALY, Regeneron, Repatha, Sanofi, cost effective, cost-effective, praluent

A new study published in JAMA has suggested that Amgen, Sanofi and Regeneron would have to reduce their prices for …

News
landing-hero-images1

ViiV Healthcare launches Phase III trial for combo HIV treatment

August 16, 2016
Research and Development Dolutegravir, HIV, Tivicay, ViiV Healthcare, epivir, lamivudine, phase III

The Pfizer/GSK spin off ViiV Healthcare has announced the beginning of a Phase III evaluating Tivicay (dolutegravir) and Epivir (lamivudine) …

News
msd

MSD to cut 148 jobs at Pennsylvania plant

August 16, 2016
Manufacturing and Production, Research and Development MSD, job cuts, zontivity

MSD is due to cut 148 jobs at its North Wales, Pennsylvania campus effective September 12, according to the company’s …

News

Ashfield launches Global Impact On Society Initiative

August 16, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield, part of UDG Healthcare plc (LON: UDG), a global leader in providing outsourced healthcare services to pharmaceutical, device and …

News
Press release

13 deaths in Aurinia’s lupus drug trial despite hitting Phase II target

August 16, 2016
Manufacturing and Production, Research and Development Aurinia, Phase II, biotech, patient deaths, voclosporin

Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …

News
kalydeco

Vertex stumbles in Phase III cystic fibrosis trials

August 16, 2016
Manufacturing and Production, Research and Development Vertex, cystic fibrosis, phase III

Vertex Pharmaceuticals has provided an update on its ongoing Phase III trials investigating VX-661 in combination with Kalydeco (ivacaftor) in …

News
ucb_logo_pole2

US court rules in favour of UCB in patent dispute, shares jump

August 16, 2016
Manufacturing and Production, Research and Development, Sales and Marketing UCB, lacosamide, patent, vimpat

UCB has received a major boost after a Delaware district court confirmed the validity of the company’s patents on one …

News

FDA finds drug class at centre of French trial tragedy do not pose similar safety risks

August 15, 2016
Manufacturing and Production, Research and Development Bial, Biotrial, FDA, faah, rennes

The US Food and Drug Administration (FDA) has issued a statement following the results of their investigation into the recent …

News
eu_flag

UK Government commits to funding EU research projects after Brexit

August 15, 2016
Manufacturing and Production, Research and Development brexit, research

Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …

News
top_ten

Top ten stories in the pharmaceutical industry this week

August 15, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …

News
shutterstock_76507048

Acute coronary syndrome market to grow to over $12 billion by 2022

August 15, 2016
Research and Development, Sales and Marketing GlobalData, acute coronary syndrome

The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …

News
doc_writing

Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug

August 15, 2016
Sales and Marketing Endo, Endo International, abuse deterrent, opioid

Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …

News
novartis_side_building

Novartis invests €100 million to expand French manufacturing plant

August 15, 2016
Manufacturing and Production, Sales and Marketing Novartis, manufacturing

Novartis has sealed the deal with construction firm Jacobs Engineering group to expand production operations at its France Center of …

News
vaccination

Sanofi launches dengue immunisation program in Brazil

August 15, 2016
Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines

Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …

News
abbvie_0

Study shows promise for Venclexta in acute myelogenous leukaemia

August 12, 2016
Research and Development, Sales and Marketing AbbVie, Genentech, Roche, Venclexta, venetoclax

A study published in Cancer Discovery, the journal of the American Association for Cancer Research, suggests that Vencletxa (venetoclax) is …

News
clinical_trial-web

Promising results for new type 2 diabetes management procedure

August 12, 2016
Research and Development, Sales and Marketing Fractyl, Revita, diabetes, type 2 diabetes

Fractyl Laboratories has revealed data from its first-in-human study of Revita duodenal mucosal resurfacing (Revita DMR), a new 60-minute, non-surgical …

News

Ashfield publishes a guide to Patient Support Programmes: Ten steps to success

August 12, 2016
Medical Communications, Research and Development, Sales and Marketing

The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put …

News
Press release
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026